Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...
Reading & Northern Railroad experienced record freight revenues in 2024, in addition to growing passenger ridership. The Port Clinton-based railroad earned more freight revenue in 2024 than in any ...